CVS Pharmacy Inc. has agreed to pay the federal government $600,000 to resolve alleged record keeping violations of the federal Controlled Substances Act at two Connecticut stores.
Federal authorities in Connecticut alleged at least 4,936 occasions when paperwork for Schedule III drugs was improperly filed or stored at a New Britain store, and at least 2,886 times at a Southington store.
The Drug Enforcement Administration describes Schedule III drugs as substances with low-to-moderate potential for physical and psychological dependence.
Authorities say accurate record keeping at retail pharmacies helps investigators keep track of how many controlled substances they should and do have on hand.
Woonsocket, R.I.-based CVS says it agreed to settle to avoid litigation. CVS says it's committed to the highest ethical and businesses standards, including complying with all laws.
